Free-base nicotine in tobacco products. Part II. Determination of free-base nicotine in the aqueous extracts of smokeless tobacco products and the relevance of these findings to product design parameters

Regulatory Toxicology and Pharmacology

Volumn 59, Issue 1, 2011, Pages 8-18

  Lauterbach, J H ^a   Bao, M ^b   Joza, P J ^b   Rickert, W S ^b  

^a Lauterbach and Associates LLC   (United States)

^b Labstat International ULC   (Canada)

Author keywords

Chewing tobacco; Free base nicotine; Nicotine; Smokeless tobacco products; Snuff; Snus; Tobacco pH

Indexed keywords

AMMONIUM CARBONATE; AMMONIUM CHLORIDE; NICOTINE; UNCLASSIFIED DRUG;

ARTICLE; BIOASSAY; CANADA; CHEMICAL ANALYSIS; GRAVIMETRY; MATHEMATICAL ANALYSIS; NORTH AMERICA; PH; PRIORITY JOURNAL; SAFETY; SMOKELESS TOBACCO; STRUCTURAL EQUATION MODELING; TOXICITY TESTING;

AMMONIA; CHEMICAL FRACTIONATION; HYDROGEN-ION CONCENTRATION; MODELS, CHEMICAL; NICOTINE; REPRODUCIBILITY OF RESULTS; TOBACCO, SMOKELESS;

NICOTIANA TABACUM;

EID: 78751570946     PISSN: 02732300     EISSN: 10960295     Source Type: Journal    
DOI: 10.1016/j.yrtph.2010.09.002     Document Type: Article

References (52)

1. Agyei-Aye K., Chian M.X., Lauterbach J.H., Moldoveanu S.C. The role of the anion in the reaction of reducing sugars with ammonium salts. Carbohydr. Res. 2002, 337:2273-2277.
2. Alford, E.D., Colby, D., Moldoveanu, S.C., 1989. Analytical results regarding direct silylation of wet snuff. Brown & Williamson Tobacco Corporation Report, November 3, 1989. (accessed 4.04.10). http://legacy.library.ucsf.edu/tid/xtj51f00.
3. Ali H., Pätzold R., Brückner H. Determination of l- and d-amino acids in smokeless tobacco products and tobacco. Food Chem. 2006, 99:803-812.
4. Alpert H.R., Koh H., Connolly G.N. Free nicotine content and strategic marketing of moist snuff tobacco products in the United States: 2000-2006. Tob. Control 2008, 17:332-338.
5. Andersson G., Björnberg G., Curvall M. Oral mucosal changes and nicotine disposition in users of Swedish smokeless tobacco products: a comparative study. J. Oral Pathol. Med. 1994, 23:161-167.
6. AOAC Official Method 966.02, Moisture in Tobacco, Gravimetric Method 1990, AOAC, AOAC International, Gaithersburg, MD.
7. Ashley D.L., Pankow J.F., Tavakoli A.D., Watson C.H. Approaches, challenges, and experience in assessing free nicotine. Handb. Exp. Pharmacol. 2009, 192:437-456.
8. Ayo-Yusuf O.A., Swart T.J., Pickworth W.B. Nicotine delivery capabilities of smokeless tobacco products and implications for control of tobacco dependence in South Africa. Tob. Control 2004, 13:186-189.
9. Banyasz, J.L., 1988. The nicotine-water-CO2 system. Philip Morris USA inter-office correspondence, April 29, 1988. (accessed 3.02.09). http://legacy.library.ucsf.edu/tid/wot17e00.
10. Carpenter C.M., Connolly G.N., Ayo-Yusuf O.A., Wayne G.F. Developing smokeless tobacco products for smokers: an examination of tobacco industry documents. Tob. Control 2009, 18:54-59.
11. Cheng K.L., Zhu D.-M. On calibration of pH meters. Sensors 2005, 5:209-219.
12. Ciolino L.A., McCauley H.A., Fraser D.B., Wolnik K.A. The relative buffering capacities of saliva and moist snuff: implications for nicotine absorption. J. Anal. Toxicol. 2001, 25:15-25.
13. Cobb, C.O., Weaver, M.F., Eissenberg, T., 2009. Evaluating the acute effects of oral, non-combustible potential reduced exposure products marketed to smokers. Tob. Control (published online April 2, 2009). doi:10.1136/tc.2008.028993.
14. Connolly G.N. The marketing of nicotine addiction by one oral snuff manufacturer. Tob. Control 1995, 4:73-79.
15. Constable P.D. Clinical assessment of acid-base status: comparison of the Henderson-Hasselbalch and strong ion approaches. Vet. Clin. Pathol. 2000, 29:115-128.
16. CSTHEA, 1986. The Comprehensive Smokeless Tobacco Health Education Act (CSTHEA), 15 U.S.C. §4403(a)(A), Public Law 99-252. (accessed 24.06.10). http://www.cdc.gov/tobacco/basic_information/tobacco_industry/reporting/descriptions/index.htm.
17. Dautzenberg B., Nides M., Kienzler J.-L., Callens A. Pharmacokinetics, safety and efficacy from randomized controlled trials of 1 and 2mg nicotine bitartrate lozenges (Nicotinell®). BMC Clin. Pharm. 2007, 7:11.
18. Djordjevic M.V., Hoffmann D., Glynn T., Connolly G.N. US commercial brands of moist snuff, 1994. I: Assessment of nicotine, moisture, and pH. Tob. Control 1995, 4:62-66.
19. Dougherty D.P., Da Conceicao Neta E.R., McFeeters R.F., Lubkin S.R., Breidt F. Semi-mechanistic partial buffer approach to modeling pH, the buffer properties, and the distribution of ionic species in complex solutions. J. Agric. Food Chem. 2006, 54:6021-6029.
20. Fant R.V., Henningfield J.E., Nelson R.A., Pickworth W.B. Pharmacokinetics and pharmacodynamics of moist snuff in humans. Tob. Control 1999, 8:387-392.
21. Federal Register, January 7, 2009. Notice Regarding Revisions to the Laboratory Protocol to Measure the Quantity of Nicotine Contained in Smokeless Tobacco Products Manufactured, Imported, or Packaged in the United States, vol. 74, No. 4, pp. 712-719.
22. Federal Register, March 14, 2008. Notice Regarding Revisions to the Laboratory Protocol to Measure the Quantity of Nicotine Contained in Smokeless Tobacco Products Manufactured, Imported, or Packaged in the United States, vol. 73, No. 51, pp. 13903-13909.
23. Federal Register, March 23, 1999. Notice Regarding Requirement for Annual Submission of the Quantity of Nicotine Contained in Smokeless Tobacco Products Manufactured, Imported, or Packaged in the United States, vol. 64, No. 55, pp. 14085-14096.
24. Fowler R.T. A redetermination of the ionization constants of nicotine. J. Appl. Chem. 1954, 4:449-452.
25. Freedman, A.M., 1994. Juiced up. How a tobacco giant doctors snuff brands to boost their kick. Wall Street J., October 26, 1994. (accessed 17.11.08). http://legacy.library.ucsf.edu/tid/ujl60c00.
26. González E., Monge C., Whittembury J. Ionization constants of 5,5'-dimethyl-2,4-oxazolidinedione (DMO) and nicotine at temperatures and NaCl concentrations of biological interest. Acta Cient. Venez. 1980, 31:128-130.
27. Henningfield J.E., Radzius A., Cone E.J. Estimation of available nicotine content of six smokeless tobacco products. Tob. Control 1995, 4:57-61.
28. Henningfield J.E., Radzius A., Cooper T.M., Clayton R.R. Drinking coffee and carbonated beverages blocks absorption of nicotine from nicotine polacrilex gum. JAMA 1990, 264:1560-1564.
29. IARC Smokeless tobacco and some tobacco-specific N-nitrosamines. IARC Monogr. Eval. Carcinog. Risks Hum. 2007, 89:1-592.
30. Kao Y.-H., Fitch C.A., Bhattacharya S., Sarkisian C.J., Lecomte J.T., García-Moreno E.B. Salt effects on ionization equilibria of histidines in myoglobin. Biophys. J. 2000, 79:1637-1654.
31. Kotlyar M., Mendoza-Baumgart M.I., Li Z.Z., Pentel P.R., Barnett B.C., Feuer R.M., Smith E.A., Hatsukami D.K. Nicotine pharmacokinetics and subjective effects of three potential reduced exposure products, moist snuff and nicotine lozenge. Tob. Control 2007, 16:138-142.
32. Kurtz I., Kraut J., Ornekian V., Nguyen M.K. Acid-base analysis: a critique of the Stewart and bicarbonate-centered approaches. Am. J. Physiol. Renal Physiol. 2008, 294:F1009-F1031.
33. Lauterbach, J.H., Grimm, D.A., 2010. Indicators of Maillard polymer formation in commercial moist snuff products. In: 239th National Meeting of the American Chemical Society, San Francisco, CA, March 21-26, 2010 (Paper CARB 108).
34. Lauterbach, J.H., Grimm, D.A., 2009. Use of two GC-MS scan techniques for the characterization of reference smokeless tobacco products. In: CORESTA Meeting, Smoke Science/Product Technology Groups, October 18-22, 2009 (Aix-en-Provence, France, Paper SSPT 11).
35. Lindemann J., Keck T., Scheithauer M.O., Leiacker R., Wiesmiller K. Nasal mucosal temperature in relation to nasal airflow as measured by rhinomanometry. Am. J. Rhinol. 2007, 21:46-49.
36. Lunell E., Lunell M. Steady-state nicotine plasma levels following use of four different types of Swedish snus compared with 2-mg Nicorette chewing gum: a crossover study. Nicotine Tob Res. 2005, 7:397-403.
37. McAdam, K., Bishop, L., Digard, H., Liu, C., Tetteh, J., 2009. Analysis of Free-base Nicotine and Volatile Ingredients in Smokeless Tobacco by Headspace-SPME GC/MS. Society for Research on Nicotine and Tobacco (SRNT), April 27-30, Saggart, Co. Dublin, Ireland.
38. Moldoveanu, S.C., Colby, D.S., 1990. Current DS scan analytical work for monitoring the fermentation of wet snuff. Brown & Williamson Tobacco Corporation Report, February 19, 1990. (accessed 4.4.10). http://legacy.library.ucsf.edu/tid/pvv21f00.
39. Nguyen M.K., Kao L., Kurtz I. Calculation of the equilibrium pH in a multiple-buffered aqueous solution based on partitioning of proton buffering: a new predictive formula. Am. J. Physiol. Renal Physiol. 2009, 296:F1521-F1529.
40. North Carolina Agricultural Research Service, 2006. The Reference Smokeless Tobacco Products and analytical data on them are available from the Tobacco Analytical Lab, Crop Science Dept., Box 8604, North Carolina State University, Raleigh, NC 27695-8604.
41. Po H.N., Senozan N.M. The Henderson-Hasselbalch equation: its history and limitations. J. Chem. Ed. 2001, 78:1499-1503.
42. Richter P., Hodge K., Stanfill S., Zhang L., Watson C. Surveillance of moist snuff: total nicotine, moisture, pH, un-ionized nicotine, and tobacco specific nitrosamines. Nicotine Tob. Res. 2008, 10:1645-1652.
43. Richter P., Spierto F.W. Surveillance of smokeless tobacco nicotine, pH, moisture, and unprotonated nicotine content. Nicotine Tob. Res. 2003, 5:885-889.
44. Rickert W.S., Joza P.J., Trivedi A.H., Momin R.A., Wagstaff W.G., Lauterbach J.H. Chemical and toxicological characterization of commercial smokeless tobacco products available on the Canadian market. Regul. Toxicol. Pharmacol. 2009, 53:121-133.
45. Sloan R.E., Keatinge W.R. Depression of sublingual temperature by cold saliva. Br. Med. J. 1975, 1(5960):718-720.
46. SmokeLess New Zealand, 2007. Nasal snuff - chemical analyses. (accessed 07.07.08). http://www.smokeless.org.nz/nasalsnuff_analyses.pdf.
47. Stepanov I., Jensen J., Hatsukami D., Hecht S.S. New and traditional smokeless tobacco: comparison of toxicant and carcinogen levels. Nicotine Tob. Res. 2008, 10:1773-1782.
48. Stewart P.A. Modern quantitative acid-base chemistry. Can. J. Physiol. Pharmacol. 1983, 61:1444-1461.
49. Swedish Match, 2010. Our business: (1) chewing tobacco, ingredients in chewing tobacco composite list, ; (2) snus and snuff, ingredients in snuff, composite list, (Note. snus and snuff list further subdivided into moist snuff, nasal snuff, and snus, all lists accessed 04.04.10). http://www.swedishmatch.com/en/Our-business/Snuff-and-snus/Ingredients-in-snuff/Composite-list/.
50. Tomar S.L., Henningfield J.E. Review of the evidence that pH is a determinant of nicotine dosage from oral use of smokeless tobacco. Tob. Control 1997, 6:219-225.
51. US Smokeless Tobacco Co., 2010. Ingredients by brand. (accessed 31.05.10). http://www.ussmokeless.com/en/cms/Products/Ingredients_Nav/Ingredients/Ingredients_by_Brand/default.aspx.
52. Williamson, J., Massey, E.D., Digard, H., 2007. Constituent comparison in smokeless tobacco products used in Europe. In: Poster Presented at the 9th Annual Society for Research on Nicotine and Tobacco Europe Conference, Madrid, Spain, October 3-6, 2007 (a copy of the poster is available on the Internet at ). http://www.bat-science.com.